Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).

Health Imported infections Migrants Travellers Trends

Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 17 02 2024
revised: 20 04 2024
accepted: 26 04 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 1 5 2024
Statut: aheadofprint

Résumé

High-speed global travel, increased trade, world population growth, migration, urbanisation and climate change have favoured the emergence and spread of pathogens. We aimed to analyse the evolution of imported infections in Spain during 2012-2022 and the potential impact of some of the abovementioned factors on differential morbidity patterns. In this retrospective study (January/2012 to December/2022), we analysed data collected by the +Redivi network across 25 health centres. The network's standardised database records new cases of imported infections, including patient demographics, travel history, pre-travel advice and diagnostic information. To assess outcome rates over time and potential interactions, we constructed penalised weighted models to reduce the bias related to a low event rate and used weighted logistic regression for morbidity outcomes. We recorded 25 632 episodes, comprising 13 913 migrants, 4047 visiting friends and relatives (VFR) immigrants, 392 VFR travellers and 7280 travellers. Most immigrants came from South America (48.3%), Sub-Saharan Africa (28.5%), North Africa (6.6%), South Central Asia (5.4%) and Central America/Caribbean (5.3%). The most common regions visited by travellers were Sub-Saharan Africa (33.5%), South America (24.5%), Central America/Caribbean (13.5%), Southeast Asia (12%) and South Central Asia (10%). The proportion of diagnoses of malaria, strongyloidiasis and unspecified self-limiting febrile syndrome < 3 weeks remained unchanged during the study period. An increased frequency of diagnosis was reported for schistosomiasis, blastocystosis, giardiasis, dengue, diarrhoea, new cases of HIV, latent and pulmonary tuberculosis; a decrease was reported for syphilis, chikungunya fever, Chagas disease and eosinophilia. We detected interactions between time and sex or type of participant across the different diagnoses. Our study underscores the importance of epidemiological data in understanding infectious diseases dynamics among travellers and migrants, emphasising how demographic shifts, migration trends and healthcare policies affect disease profiles. Comprehensive data play an essential role in enhancing public health policies and travel advice.

Sections du résumé

BACKGROUND BACKGROUND
High-speed global travel, increased trade, world population growth, migration, urbanisation and climate change have favoured the emergence and spread of pathogens. We aimed to analyse the evolution of imported infections in Spain during 2012-2022 and the potential impact of some of the abovementioned factors on differential morbidity patterns.
METHODS METHODS
In this retrospective study (January/2012 to December/2022), we analysed data collected by the +Redivi network across 25 health centres. The network's standardised database records new cases of imported infections, including patient demographics, travel history, pre-travel advice and diagnostic information. To assess outcome rates over time and potential interactions, we constructed penalised weighted models to reduce the bias related to a low event rate and used weighted logistic regression for morbidity outcomes.
RESULTS RESULTS
We recorded 25 632 episodes, comprising 13 913 migrants, 4047 visiting friends and relatives (VFR) immigrants, 392 VFR travellers and 7280 travellers. Most immigrants came from South America (48.3%), Sub-Saharan Africa (28.5%), North Africa (6.6%), South Central Asia (5.4%) and Central America/Caribbean (5.3%). The most common regions visited by travellers were Sub-Saharan Africa (33.5%), South America (24.5%), Central America/Caribbean (13.5%), Southeast Asia (12%) and South Central Asia (10%). The proportion of diagnoses of malaria, strongyloidiasis and unspecified self-limiting febrile syndrome < 3 weeks remained unchanged during the study period. An increased frequency of diagnosis was reported for schistosomiasis, blastocystosis, giardiasis, dengue, diarrhoea, new cases of HIV, latent and pulmonary tuberculosis; a decrease was reported for syphilis, chikungunya fever, Chagas disease and eosinophilia. We detected interactions between time and sex or type of participant across the different diagnoses.
CONCLUSIONS CONCLUSIONS
Our study underscores the importance of epidemiological data in understanding infectious diseases dynamics among travellers and migrants, emphasising how demographic shifts, migration trends and healthcare policies affect disease profiles. Comprehensive data play an essential role in enhancing public health policies and travel advice.

Identifiants

pubmed: 38691427
pii: 7660945
doi: 10.1093/jtm/taae067
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Yam Alkaissy (Y)

Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Nuria Serre-Delcor (N)

International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.

Marta Arsuaga Vicente (MA)

CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.
National Referral Unit for Imported Infectious Diseases. Hospital La Paz-Carlos III, Madrid, Spain.

Israel Molina (I)

CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.
Tropical Medicine Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.

Francesca F Norman (FF)

CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.
National Reference Centre for Imported Tropical Diseases. Infectious Diseases Department. Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Ane Josune Goikoetxea (AJ)

Cruces University Hospital, Barakaldo, Bilbao, Spain.

Begoña de Dios (B)

Department of Internal Medicine. Hospital Universitario 12 de Octubre, Madrid, Spain.

Diego Torrús (D)

Unidad de Referencia de Enfermedades Importadas y Salud Internacional, Unidad de Enfermedades Infecciosas, Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.

Miguel Nicolás Navarrete Lorite (MNN)

Unidad Clínica de Enfermedades Infecciosas y Microbiologia del Hospital Universitario Virgen Macarena, Sevilla, Spain.

Azucena Rodríguez-Guardado (A)

Área de Gestión Clínica Medicina Interna. Hospital Universitario Central de Asturias, Oviedo, Spain.
Grupo de Microbiología Traslacional. Instituto de Investigación del Principado de Asturias.

Itxaso Lombide (I)

Basurto University Hospital, Bilbao, Spain.

Eva Calabuig (E)

La Fe University and Polytechnic Hospital, University of Valencia, Valencia, Spain.

Alfonso Muriel (A)

Clinical Biostatistic Unit, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.
Universidad de Alcalá, Alcalá de Henares, Spain.

Jose A Perez-Molina (JA)

CIBERINFEC. Instituto de Salud Carlos III, Madrid, Spain.
National Reference Centre for Imported Tropical Diseases. Infectious Diseases Department. Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Classifications MeSH